Portal de Periódicos da CAPES

Treatment of Paget's Disease of Bone with Mithramycin

1971; BMJ; Volume: 1; Issue: 5746 Linguagem: Inglês

10.1136/bmj.1.5746.421

0959-8138

John R Condon, Schroedel Reith, J. R. Nassim, F J Millard, A. Hilb, E. M. Stainthorpe,

Bone and Joint Diseases

We report data from three patients with severe Paget's disease of bone who were treated with mithramycin.Mithramycin infusion resulted in a fall in plasma calcium, phosphate, alkaline phosphatase, and urinary hydroxyproline excretion. There was an improvement in calcium and phosphorus balance in two of the three subjects studied. A pronounced or complete relief of bone pain occurred in all three.We suggest that mithramycin exerts its beneficial effect in Paget's disease of bone by stimulating parathyroid hormone release. The parathyroid hormone released has a predominantly anabolic action on bone since its catabolic action is blocked by mithramycin, which inhibits bone resorption.